To Assess the Relative Bioavailability (BA) of TRIUMEQ® and Dolutegravir and Lamivudine (DTG/3TC) Pediatric Dispersible Tablet Formulations in Healthy Volunteers
Clinical trial NCT03441984 · COMPLETED
Trial details
- NCT number
- NCT03441984
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-26
- Primary completion
- 2018-04-28
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.